The 12 closest competitors and alternatives to Autonomix Medical, Inc. among medical devices companies — ranked by similarity to what Autonomix Medical, Inc. actually does, not by market-cap band.
Subscribe to see Autonomix Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.
Autonomix Medical, Inc. is a medical devices company headquartered in The Woodlands, United States. It is publicly listed (AMIX) with a market capitalisation of $2M. Xcout tracks 16 named people at Autonomix Medical, Inc., including Bradley Hauser (Chief Executive Officer & President).
10 more named people on record for Autonomix Medical, Inc., with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to Autonomix Medical, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Therapeutic Devices
Nervonik is a medical technology company headquartered in Los Angeles, California, focusing on neuromodulation devices. The company develops next-generation peripheral nerve stimulation technology engineered to integrate dynamic stimulation for high-motion activities.
Similar medical devices company
XCath, Inc. is a healthcare and medical technology company headquartered in Houston, Texas, that develops microsurgical robotic devices.
Similar medical devices company
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
Similar medical devices company
MicroTransponder, Inc. (also known as Mobia Medical, Inc.) is a commercial-stage medical device company headquartered in Austin, Texas. The company's core facilities host operations dedicated to developing its medical technologies and therapeutic solutions.
Similar medical devices company
Procyrion, Inc. is a Houston, Texas-based heart pump developer. The company focuses on the research, expansion, and development of its Aortix circulatory support device for investigational use.
Similar medical devices company
Motif Neurotech is a medical equipment and therapeutic brain-computer interface company headquartered in Houston, Texas. The company develops minimally invasive bioelectronic devices designed to provide therapeutic relief for mental health disorders.
Similar medical devices company
Tulavi Nerve Therapeutics is a medical device company headquartered in Hamilton, Canada, dedicated to developing therapeutic devices that target nerves to treat neurally mediated diseases.
Similar medical devices company
Neurinnov is a medical technology company based in Montpellier, France, specializing in innovation within neurostimulation. The firm has developed a versatile technology platform designed to restore human functions in individuals suffering from functional deficiencies across multiple pathologies. Through its specialized medical research, the company creates clinical value and therapeutic solutions.
Similar medical devices company
Lunair Medical is developing an implantable neurostimulation device and connected digital platform designed to treat moderate-to-severe sleep apnea. The system utilizes closed-loop phrenic nerve stimulation and respiration sensing to maintain an open airway during sleep without the use of masks or wearables.
Similar medical devices company
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.
Similar medical devices company
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Similar medical devices company
Verve Medical, Inc. is an early-stage medical device company headquartered in Phoenix, Arizona, focused on developing novel trans-urethral and natural orifice renal denervation devices.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Autonomix Medical, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →